Why, when, and how to assess pulmonary congestion in heart failure: pathophysiological, clinical, and methodological implications.

Heart failure reviews

Volumn 15, Issue 1, 2010, Pages 63-72

  Picano, Eugenio ^a   Gargani, Luna ^a   Gheorghiade, Mihai ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; LENGTH OF STAY; LUNG EDEMA; MONITORING; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SURVIVAL;

DIURETICS; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; LENGTH OF STAY; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PULMONARY EDEMA; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 77950353970     PISSN: None     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-009-9148-8     Document Type: Review

References (42)